|1.||Gavva, Narender R: 2 articles (06/2008 - 07/2007)|
|2.||Wu, Chaoran: 1 article (06/2008)|
|3.||Brennan, Timothy J: 1 article (06/2008)|
|4.||Norman, Mark H: 1 article (07/2007)|
|5.||Burmeister, Jeffrey J: 1 article (07/2007)|
|6.||Almeida, Maria C: 1 article (07/2007)|
|7.||Oliveira, Daniela L: 1 article (07/2007)|
|8.||Bannon, Anthony W: 1 article (07/2007)|
|9.||Roberts, Jennifer L: 1 article (07/2007)|
|10.||Romanovsky, Andrej A: 1 article (07/2007)|
07/11/2007 - "AMG0347 was no more effective in causing hyperthermia when administered into the brain (intracerebroventricularly) or spinal cord (intrathecally) than when given systemically (intravenously), which indicates a peripheral site of action. "
07/11/2007 - "The magnitude of the hyperthermic response depended on neither T(b) nor tail-skin temperature at the time of AMG0347 administration, thus indicating that AMG0347-induced hyperthermia results from blockade of tonic TRPV1 activation by nonthermal factors. "
06/01/2008 - "The current study examined the analgesic effects of a recently developed transient receptor potential vanilloid 1 (TRPV1) antagonist, AMG0347, on incisional pain in rats. "
06/01/2008 - "For incisional pain, AMG0347 did not change the withdrawal threshold to mechanical stimulation or the guarding pain score. "
06/01/2008 - "The effect of either AMG0347 or morphine was tested for its effects on guarding pain score, heat withdrawal latency, and mechanical withdrawal threshold. "
06/01/2008 - "Effect of AMG0347, a transient receptor potential type V1 receptor antagonist, and morphine on pain behavior after plantar incision."
|1.||Vasopressin Receptors (Arginine Vasopressin Receptor)
|2.||Morphine (MS Contin)